{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:50:13Z","timestamp":1793713813586,"version":"4.6.1"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guizhou Provincial Basic Research Program","award":["ZK [2024] General 319"],"award-info":[{"award-number":["ZK [2024] General 319"]}]},{"name":"Guizhou Provincial Administration of Traditional Chinese Medicine","award":["QZYY-2025-035"],"award-info":[{"award-number":["QZYY-2025-035"]}]},{"name":"Zunyi City Bureau of Science and Technology and Big Data","award":["Zun City Ke He HZ word (2023)266"],"award-info":[{"award-number":["Zun City Ke He HZ word (2023)266"]}]},{"DOI":"10.13039\/100017957","name":"Health Commission of Guizhou Province","doi-asserted-by":"publisher","award":["2024GZWJKJXM0770"],"award-info":[{"award-number":["2024GZWJKJXM0770"]}],"id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05629-3","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:57:24Z","timestamp":1766527044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer\u2019s Disease and Cardiovascular Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Chan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Mei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"2","key":"5629_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J et al (2024) Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci 25(2):91\u2013110","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"5629_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14279-8","volume":"11","author":"EM Reiman","year":"2020","unstructured":"Reiman EM et al (2020) Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun 11(1):667","journal-title":"Nat Commun"},{"key":"5629_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glae246","author":"MM Dunk","year":"2025","unstructured":"Dunk MM et al (2025) Relationships between APOE, type 2 diabetes, and cardiovascular disease in postmenopausal women. J Gerontol A Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/gerona\/glae246","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"5629_CR4","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","volume":"298","author":"AM Bennet","year":"2007","unstructured":"Bennet AM et al (2007) Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298(11):1300\u20131311","journal-title":"JAMA"},{"issue":"2","key":"5629_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen Y et al (2021) Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron 109(2):205\u2013221","journal-title":"Neuron"},{"issue":"1","key":"5629_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1172\/JCI115288","volume":"88","author":"MF Linton","year":"1991","unstructured":"Linton MF et al (1991) Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest 88(1):270\u201381","journal-title":"J Clin Invest"},{"issue":"13","key":"5629_CR7","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1073\/pnas.95.13.7585","volume":"95","author":"Y Zhu","year":"1998","unstructured":"Zhu Y et al (1998) Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma. Proc Natl Acad Sci U S A 95(13):7585\u201390","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"5629_CR8","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2023.12.018","volume":"112","author":"MR Strickland","year":"2024","unstructured":"Strickland MR et al (2024) Apolipoprotein E secreted by astrocytes forms antiparallel dimers in discoidal lipoproteins. Neuron 112(7):1100-1109 e5","journal-title":"Neuron"},{"issue":"8","key":"5629_CR9","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0022-2275(20)31574-1","volume":"42","author":"H Campos","year":"2001","unstructured":"Campos H et al (2001) Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res 42(8):1239\u201349","journal-title":"J Lipid Res"},{"issue":"11","key":"5629_CR10","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1161\/ATVBAHA.120.314609","volume":"40","author":"FM Sacks","year":"2020","unstructured":"Sacks FM et al (2020) Protein-defined subspecies of HDLs (high-density lipoproteins) and differential risk of coronary heart disease in 4 prospective studies. Arterioscler Thromb Vasc Biol 40(11):2714\u20132727","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"5629_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000130","volume":"2","author":"CO Mendivil","year":"2013","unstructured":"Mendivil CO et al (2013) Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease. J Am Heart Assoc 2(3):e000130","journal-title":"J Am Heart Assoc"},{"key":"5629_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/membranes13050471","author":"F Weber","year":"2023","unstructured":"Weber F et al (2023) Lipoprotein particles as shuttles for hydrophilic cargo. Membranes. https:\/\/doi.org\/10.3390\/membranes13050471","journal-title":"Membranes"},{"issue":"6","key":"5629_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuron.2021.01.005","volume":"109","author":"X Li","year":"2021","unstructured":"Li X et al (2021) Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory. Neuron 109(6):957-970 e8","journal-title":"Neuron"},{"issue":"1","key":"5629_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi G et al (2021) ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism. Cell Rep 34(1):108572","journal-title":"Cell Rep"},{"issue":"32","key":"5629_CR15","doi-asserted-by":"publisher","first-page":"19053","DOI":"10.1074\/jbc.271.32.19053","volume":"271","author":"LM Dong","year":"1996","unstructured":"Dong LM, Weisgraber KH (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271(32):19053\u201319057","journal-title":"J Biol Chem"},{"issue":"7","key":"5629_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","volume":"94","author":"RW Mahley","year":"2016","unstructured":"Mahley RW (2016) Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med (Berl) 94(7):739\u2013746","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"5629_CR17","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0022-2275(20)42621-5","volume":"31","author":"KH Weisgraber","year":"1990","unstructured":"Weisgraber KH (1990) Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res 31(8):1503\u20131511","journal-title":"J Lipid Res"},{"issue":"4","key":"5629_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/ATVBAHA.112.301193","volume":"33","author":"H Li","year":"2013","unstructured":"Li H et al (2013) Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels. Arterioscler Thromb Vasc Biol 33(4):687\u201393","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"5629_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100425","volume":"64","author":"L Atehortua","year":"2023","unstructured":"Atehortua L et al (2023) Apolipoprotein E-containing HDL decreases caspase-dependent apoptosis of memory regulatory T lymphocytes. J Lipid Res 64(9):100425","journal-title":"J Lipid Res"},{"issue":"2","key":"5629_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/01.ATV.2.2.114","volume":"2","author":"TL Innerarity","year":"1982","unstructured":"Innerarity TL, Pitas RE, Mahley RW (1982) Modulating effects of canine high density lipoproteins on cholesteryl ester synthesis induced by beta-very low density lipoproteins in macrophages. Possible in vitro correlates with atherosclerosis. Arteriosclerosis 2(2):114\u2013124","journal-title":"Arteriosclerosis"},{"issue":"5","key":"5629_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1172\/JCI27602","volume":"116","author":"F Matsuura","year":"2006","unstructured":"Matsuura F (2006) HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest 116(5):1435\u201342","journal-title":"J Clin Invest"},{"issue":"3","key":"5629_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1021\/bi9013227","volume":"49","author":"L Gaidukov","year":"2010","unstructured":"Gaidukov L et al (2010) ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I. Biochemistry 49(3):532\u2013538","journal-title":"Biochemistry"},{"issue":"49","key":"5629_CR23","doi-asserted-by":"publisher","first-page":"46011","DOI":"10.1074\/jbc.M104812200","volume":"276","author":"AK Stannard","year":"2001","unstructured":"Stannard AK et al (2001) Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Biol Chem 276(49):46011\u20136","journal-title":"J Biol Chem"},{"issue":"1\u20133","key":"5629_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0014-5793(03)00261-8","volume":"540","author":"SM Sacre","year":"2003","unstructured":"Sacre SM, Stannard AK, Owen JS (2003) Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells. FEBS Lett 540(1\u20133):181\u20137","journal-title":"FEBS Lett"},{"issue":"6","key":"5629_CR25","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","volume":"177","author":"MS Ioannou","year":"2019","unstructured":"Ioannou MS et al (2019) Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell 177(6):1522-1535 e14","journal-title":"Cell"},{"issue":"10","key":"5629_CR26","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1042\/BCJ20180068","volume":"475","author":"I Dafnis","year":"2018","unstructured":"Dafnis I et al (2018) ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Abeta production independently of their cholesterol efflux capacity. Biochem J 475(10):1839\u20131859","journal-title":"Biochem J"},{"key":"5629_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100715","volume":"296","author":"JM Cooper","year":"2021","unstructured":"Cooper JM et al (2021) Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism. J Biol Chem 296:100715","journal-title":"J Biol Chem"},{"issue":"4","key":"5629_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100350","volume":"64","author":"AG Cashikar","year":"2023","unstructured":"Cashikar AG et al (2023) Regulation of astrocyte lipid metabolism and ApoE\u00a0secretionby the microglial oxysterol, 25-hydroxycholesterol. J Lipid Res 64(4):100350","journal-title":"J Lipid Res"},{"issue":"6","key":"5629_CR29","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/glia.23974","volume":"69","author":"MF Lanfranco","year":"2021","unstructured":"Lanfranco MF et al (2021) Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia 69(6):1478\u20131493","journal-title":"Glia"},{"issue":"5","key":"5629_CR30","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1074\/jbc.M309475200","volume":"279","author":"FM Harris","year":"2004","unstructured":"Harris FM et al (2004) Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer\u2019s disease. J Biol Chem 279(5):3862\u20133868","journal-title":"J Biol Chem"},{"issue":"4","key":"5629_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.tcb.2023.09.004","volume":"34","author":"IA Windham","year":"2024","unstructured":"Windham IA, Cohen S (2024) The cell biology of APOE in the brain. Trends Cell Biol 34(4):338\u2013348","journal-title":"Trends Cell Biol"},{"key":"5629_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-90-481-8622-8_7","volume":"51","author":"S Lund-Katz","year":"2010","unstructured":"Lund-Katz S, Phillips MC (2010) High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem 51:183\u2013227","journal-title":"Subcell Biochem"},{"issue":"39","key":"5629_CR33","doi-asserted-by":"publisher","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE et al (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279(39):40987\u201393","journal-title":"J Biol Chem"},{"issue":"5\u20136","key":"5629_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0197-0186(01)00049-3","volume":"39","author":"RB DeMattos","year":"2001","unstructured":"DeMattos RB et al (2001) Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem Int 39(5\u20136):415\u201325","journal-title":"Neurochem Int"},{"issue":"5","key":"5629_CR35","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1046\/j.1471-4159.1998.70052070.x","volume":"70","author":"MJ LaDu","year":"1998","unstructured":"LaDu MJ et al (1998) Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem 70(5):2070\u201381","journal-title":"J Neurochem"},{"issue":"42","key":"5629_CR36","doi-asserted-by":"publisher","first-page":"30001","DOI":"10.1074\/jbc.274.42.30001","volume":"274","author":"AM Fagan","year":"1999","unstructured":"Fagan AM et al (1999) Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-\/-), and human apoE transgenic mice. J Biol Chem 274(42):30001\u20137","journal-title":"J Biol Chem"},{"issue":"5","key":"5629_CR37","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1194\/jlr.M800584-JLR200","volume":"50","author":"V Hirsch-Reinshagen","year":"2009","unstructured":"Hirsch-Reinshagen V et al (2009) LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins. J Lipid Res 50(5):885\u201393","journal-title":"J Lipid Res"},{"key":"5629_CR38","doi-asserted-by":"crossref","unstructured":"Warden, C.H., et al., Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin: cholesterol acyltransferase gene. Evidence for expression in brain and testes as well as liver. J Biol Chem, 1989. 264(36): p. 21573\u201381.","DOI":"10.1016\/S0021-9258(20)88222-2"},{"issue":"3","key":"5629_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF02591418","volume":"22","author":"JJ Albers","year":"1992","unstructured":"Albers JJ, Marcovina SM, Christenson RH (1992) Lecithin cholesterol acyltransferase in human cerebrospinal fluid: reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain. Int J Clin Lab Res 22(3):169\u2013172","journal-title":"Int J Clin Lab Res"},{"issue":"29","key":"5629_CR40","doi-asserted-by":"publisher","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","volume":"262","author":"RE Pitas","year":"1987","unstructured":"Pitas RE et al (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem 262(29):14352\u201360","journal-title":"J Biol Chem"},{"issue":"2","key":"5629_CR41","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1074\/jbc.M510851200","volume":"281","author":"CA Peters-Libeu","year":"2006","unstructured":"Peters-Libeu CA et al (2006) Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem 281(2):1073\u20139","journal-title":"J Biol Chem"},{"issue":"5","key":"5629_CR42","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1194\/jlr.M600545-JLR200","volume":"48","author":"CA Peters-Libeu","year":"2007","unstructured":"Peters-Libeu CA et al (2007) Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution. J Lipid Res 48(5):1035\u201344","journal-title":"J Lipid Res"},{"issue":"6","key":"5629_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006165","volume":"14","author":"N Henry","year":"2018","unstructured":"Henry N et al (2018) Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach. PLoS Comput Biol 14(6):e1006165","journal-title":"PLoS Comput Biol"},{"issue":"24","key":"5629_CR44","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1073\/pnas.1705080114","volume":"114","author":"C Frieden","year":"2017","unstructured":"Frieden C, Wang H, Ho CMW (2017) A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions. Proc Natl Acad Sci U S A 114(24):6292\u20136297","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5629_CR45","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1046\/j.1471-4159.1995.64020895.x","volume":"64","author":"H Jurevics","year":"1995","unstructured":"Jurevics H, Morell P (1995) Cholesterol for synthesis of myelin is made locally, not imported into brain. J Neurochem 64(2):895\u2013901","journal-title":"J Neurochem"},{"key":"5629_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121890","author":"E Staurenghi","year":"2021","unstructured":"Staurenghi E et al (2021) Cholesterol dysmetabolism in Alzheimer\u2019s disease: a starring role for astrocytes? Antioxidants. https:\/\/doi.org\/10.3390\/antiox10121890","journal-title":"Antioxidants"},{"issue":"4","key":"5629_CR47","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Q (2015) Cholesterol metabolism and homeostasis in the brain. Protein Cell 6(4):254\u2013264","journal-title":"Protein Cell"},{"issue":"10","key":"5629_CR48","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41582-023-00864-5","volume":"19","author":"M Valenza","year":"2023","unstructured":"Valenza M, Birolini G, Cattaneo E (2023) The translational potential of cholesterol-based therapies for neurological disease. Nat Rev Neurol 19(10):583\u2013598","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"5629_CR49","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","volume":"36","author":"RW Mahley","year":"2016","unstructured":"Mahley RW (2016) Central nervous system lipoproteins: apoE and regulation of cholesterol metabolism. Arterioscler Thromb Vasc Biol 36(7):1305\u20131315","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"5629_CR50","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41593-023-01568-1","volume":"27","author":"PR Haynes","year":"2024","unstructured":"Haynes PR et al (2024) A neuron-glia lipid metabolic cycle couples daily sleep to mitochondrial homeostasis. Nat Neurosci 27(4):666\u2013678","journal-title":"Nat Neurosci"},{"key":"5629_CR51","doi-asserted-by":"crossref","unstructured":"Getz GS, and Reardon CA (2009) Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J Lipid Res 50 Suppl(Suppl): p. S156\u201361","DOI":"10.1194\/jlr.R800058-JLR200"},{"issue":"5","key":"5629_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00109-004-0631-3","volume":"83","author":"K Greenow","year":"2005","unstructured":"Greenow K, Pearce NJ, Ramji DP (2005) The key role of apolipoprotein E in atherosclerosis. J Mol Med (Berl) 83(5):329\u2013342","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"5629_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00566-4","volume":"17","author":"R Fernandez-Calle","year":"2022","unstructured":"Fernandez-Calle R et al (2022) APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases. Mol Neurodegener 17(1):62","journal-title":"Mol Neurodegener"},{"issue":"12","key":"5629_CR54","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41556-021-00805-8","volume":"23","author":"Q Zhang","year":"2021","unstructured":"Zhang Q et al (2021) Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets. Nat Cell Biol 23(12):1240\u20131254","journal-title":"Nat Cell Biol"},{"key":"5629_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.44","author":"DK Jeppesen","year":"2022","unstructured":"Jeppesen DK et al (2022) Are supermeres a distinct nanoparticle? J Extracell Biol. https:\/\/doi.org\/10.1002\/jex2.44","journal-title":"J Extracell Biol"},{"issue":"3","key":"5629_CR56","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","volume":"20","author":"H Zhang","year":"2018","unstructured":"Zhang H et al (2018) Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol 20(3):332\u2013343","journal-title":"Nat Cell Biol"},{"issue":"2","key":"5629_CR57","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen DK et al (2019) Reassessment of exosome composition. Cell 177(2):428-445.e18","journal-title":"Cell"},{"issue":"1","key":"5629_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu M et al (2019) Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol 21(1):9\u201317","journal-title":"Nat Cell Biol"},{"issue":"27","key":"5629_CR59","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1021\/acs.biochem.6b00389","volume":"55","author":"S Filou","year":"2016","unstructured":"Filou S et al (2016) Distinct roles of apolipoproteins A1 and E in the modulation of high-density lipoprotein composition and function. Biochemistry 55(27):3752\u20133762","journal-title":"Biochemistry"},{"issue":"3","key":"5629_CR60","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/clinchem\/hvac216","volume":"69","author":"B Lidgard","year":"2023","unstructured":"Lidgard B et al (2023) High-density lipoprotein lipidomics in chronic kidney disease. Clin Chem 69(3):273\u2013282","journal-title":"Clin Chem"},{"issue":"3","key":"5629_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2024.100954","volume":"7","author":"B Lidgard","year":"2025","unstructured":"Lidgard B et al (2025) High-density lipoprotein lipidomics, endothelial dysfunction, and fistula maturation in patients with advanced chronic kidney disease. Kidney Med 7(3):100954","journal-title":"Kidney Med"},{"issue":"7883","key":"5629_CR62","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","volume":"599","author":"KA Guttenplan","year":"2021","unstructured":"Guttenplan KA et al (2021) Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature 599(7883):102\u2013107","journal-title":"Nature"},{"issue":"14","key":"5629_CR63","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","volume":"26","author":"J Zhao","year":"2017","unstructured":"Zhao J et al (2017) APOE epsilon4\/epsilon4 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum Mol Genet 26(14):2690\u20132700","journal-title":"Hum Mol Genet"},{"issue":"5","key":"5629_CR64","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1194\/jlr.R034991","volume":"54","author":"KJ Rayner","year":"2013","unstructured":"Rayner KJ, Hennessy EJ (2013) Extracellular communication via microRNA: lipid particles have a new message. J Lipid Res 54(5):1174\u20131181","journal-title":"J Lipid Res"},{"issue":"7","key":"5629_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-021-00930-7","volume":"23","author":"KC Vickers","year":"2021","unstructured":"Vickers KC, Michell DL (2021) HDL-small RNA export, transport, and functional delivery in atherosclerosis. Curr Atheroscler Rep 23(7):38","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"5629_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/ATVBAHA.112.300139","volume":"33","author":"RA Boon","year":"2013","unstructured":"Boon RA, Vickers KC (2013) Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 33(2):186\u2013192","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5629_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cca.2016.12.031","volume":"466","author":"R Sodi","year":"2017","unstructured":"Sodi R et al (2017) Relationship between circulating microRNA-30c with total- and LDL-cholesterol, their circulatory transportation and effect of statins. Clin Chim Acta 466:13\u201319","journal-title":"Clin Chim Acta"},{"issue":"2","key":"5629_CR68","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jnr.24344","volume":"97","author":"T Veremeyko","year":"2019","unstructured":"Veremeyko T et al (2019) Neuronal extracellular microRNAs miR-124 and miR-9 mediate cell-cell communication between neurons and microglia. J Neurosci Res 97(2):162\u2013184","journal-title":"J Neurosci Res"},{"issue":"1","key":"5629_CR69","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12944-020-01291-x","volume":"19","author":"M Amaya-Montoya","year":"2020","unstructured":"Amaya-Montoya M et al (2020) ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity. Lipids Health Dis 19(1):106","journal-title":"Lipids Health Dis"},{"issue":"9","key":"5629_CR70","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1073\/pnas.76.9.4646","volume":"76","author":"PS Roheim","year":"1979","unstructured":"Roheim PS et al (1979) Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A 76(9):4646\u20134649","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"5629_CR71","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","volume":"42","author":"S Koch","year":"2001","unstructured":"Koch S et al (2001) Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res 42(7):1143\u20131151","journal-title":"J Lipid Res"},{"issue":"35","key":"5629_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi5571","volume":"9","author":"NJ Merrill","year":"2023","unstructured":"Merrill NJ et al (2023) Human cerebrospinal fluid contains diverse lipoprotein subspecies enriched in proteins implicated in central nervous system health. Sci Adv 9(35):eadi5571","journal-title":"Sci Adv"},{"issue":"5","key":"5629_CR73","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/ATVBAHA.123.318284","volume":"44","author":"M Tsujita","year":"2024","unstructured":"Tsujita M, Melchior JT, Yokoyama S (2024) Lipoprotein particles in cerebrospinal fluid. Arterioscler Thromb Vasc Biol 44(5):1042\u20131052","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5629_CR74","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1073\/pnas.82.1.203","volume":"82","author":"NA Elshourbagy","year":"1985","unstructured":"Elshourbagy NA et al (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A 82(1):203\u2013207","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5629_CR75","doi-asserted-by":"crossref","unstructured":"Mahley RW, Weisgraber KH, and Huang\u00a0Y (2009) Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 50 Suppl(Suppl): p. S183\u20138","DOI":"10.1194\/jlr.R800069-JLR200"},{"issue":"20","key":"5629_CR76","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1093\/hmg\/dds296","volume":"21","author":"C Cruchaga","year":"2012","unstructured":"Cruchaga C et al (2012) Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer\u2019s disease. Hum Mol Genet 21(20):4558\u20134571","journal-title":"Hum Mol Genet"},{"key":"5629_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-2-7","volume":"2","author":"SE Wahrle","year":"2007","unstructured":"Wahrle SE et al (2007) Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Mol Neurodegener 2:7","journal-title":"Mol Neurodegener"},{"issue":"45","key":"5629_CR78","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","volume":"28","author":"DR Riddell","year":"2008","unstructured":"Riddell DR et al (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28(45):11445\u201311453","journal-title":"J Neurosci"},{"issue":"5","key":"5629_CR79","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ana.21099","volume":"61","author":"JS Kauwe","year":"2007","unstructured":"Kauwe JS et al (2007) Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer\u2019s disease presenilin 1 mutation. Ann Neurol 61(5):446\u2013453","journal-title":"Ann Neurol"},{"issue":"4","key":"5629_CR80","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1615\/CritRevNeurobiol.v13.i4.20","volume":"13","author":"M Danik","year":"1999","unstructured":"Danik M et al (1999) Brain lipoprotein metabolism and its relation to neurodegenerative disease. Crit Rev Neurobiol 13(4):357\u2013407","journal-title":"Crit Rev Neurobiol"},{"issue":"5","key":"5629_CR81","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00401-014-1266-2","volume":"127","author":"E Martinez-Morillo","year":"2014","unstructured":"Martinez-Morillo E et al (2014) Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients and controls. Acta Neuropathol 127(5):633\u2013643","journal-title":"Acta Neuropathol"},{"issue":"9","key":"5629_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2021.158980","volume":"1866","author":"AB Chai","year":"2021","unstructured":"Chai AB et al (2021) Apolipoprotein E isoform-dependent effects on the processing of Alzheimer\u2019s amyloid-beta. Biochim Biophys Acta Mol Cell Biol Lipids 1866(9):158980","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"51","key":"5629_CR83","doi-asserted-by":"publisher","first-page":"18700","DOI":"10.1073\/pnas.0508693102","volume":"102","author":"S Ye","year":"2005","unstructured":"Ye S et al (2005) Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci U S A 102(51):18700\u201318705","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5629_CR84","doi-asserted-by":"crossref","unstructured":"Huang YA et al (2017)\u00a0ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and Abeta secretion. Cell 168(3): p. 427\u2013441 e21","DOI":"10.1016\/j.cell.2016.12.044"},{"issue":"17","key":"5629_CR85","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ et al (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90(17):8098\u20138102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"5629_CR86","doi-asserted-by":"publisher","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu MJ et al (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 269(38):23403\u201323406","journal-title":"J Biol Chem"},{"issue":"16","key":"5629_CR87","doi-asserted-by":"publisher","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","volume":"270","author":"MJ LaDu","year":"1995","unstructured":"LaDu MJ et al (1995) Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J Biol Chem 270(16):9039\u20139042","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"5629_CR88","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/bj3480359","volume":"348","author":"T Tokuda","year":"2000","unstructured":"Tokuda T et al (2000) Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer\u2019s amyloid beta peptides. Biochem J 348(Pt 2):359\u201365","journal-title":"Biochem J"},{"issue":"5","key":"5629_CR89","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell RD et al (2007) Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27(5):909\u2013918","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"5629_CR90","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R et al (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118(12):4002\u20134013","journal-title":"J Clin Invest"},{"issue":"19","key":"5629_CR91","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB et al (2013) ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions. Proc Natl Acad Sci U S A 110(19):E1807\u2013E1816","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5629_CR92","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-016-0099-y","volume":"11","author":"Y Fu","year":"2016","unstructured":"Fu Y et al (2016) Apolipoprotein E lipoprotein particles inhibit amyloid-beta uptake through cell surface heparan sulphate proteoglycan. Mol Neurodegener 11(1):37","journal-title":"Mol Neurodegener"},{"issue":"3","key":"5629_CR93","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/nn4058215","volume":"8","author":"Q Song","year":"2014","unstructured":"Song Q et al (2014) Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer\u2019s disease by accelerating the clearance of amyloid-beta. ACS Nano 8(3):2345\u20132359","journal-title":"ACS Nano"},{"issue":"5","key":"5629_CR94","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani AR et al (2019) Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in Alzheimer disease. Ann Neurol 85(5):726\u2013739","journal-title":"Ann Neurol"},{"issue":"7673","key":"5629_CR95","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y et al (2017) ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549(7673):523\u2013527","journal-title":"Nature"},{"issue":"1","key":"5629_CR96","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","volume":"9","author":"N Zhao","year":"2018","unstructured":"Zhao N et al (2018) APOE epsilon2 is associated with increased tau pathology in primary tauopathy. Nat Commun 9(1):4388","journal-title":"Nat Commun"},{"key":"5629_CR97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2015.09.011","volume":"37","author":"JM Farfel","year":"2016","unstructured":"Farfel JM et al (2016) Association of APOE with tau-tangle pathology with and without beta-amyloid. Neurobiol Aging 37:19\u201325","journal-title":"Neurobiol Aging"},{"issue":"7803","key":"5629_CR98","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN et al (2020) LRP1 is a master regulator of tau uptake and spread. Nature 580(7803):381\u2013385","journal-title":"Nature"},{"issue":"5","key":"5629_CR99","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.stemcr.2022.03.018","volume":"17","author":"SM de Leeuw","year":"2022","unstructured":"de Leeuw SM et al (2022) APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes. Stem Cell Rep 17(5):1229\u20131231","journal-title":"Stem Cell Rep"},{"issue":"3","key":"5629_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112196","volume":"42","author":"S Lee","year":"2023","unstructured":"Lee S et al (2023) APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep 42(3):112196","journal-title":"Cell Rep"},{"issue":"4","key":"5629_CR101","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu Y et al (2012) APOE genotype alters glial activation and loss of synaptic markers in mice. Glia 60(4):559\u2013569","journal-title":"Glia"},{"issue":"3","key":"5629_CR102","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.nbd.2005.05.002","volume":"20","author":"G Ophir","year":"2005","unstructured":"Ophir G et al (2005) Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade. Neurobiol Dis 20(3):709\u2013718","journal-title":"Neurobiol Dis"},{"issue":"6","key":"5629_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.06.011","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT et al (2018) APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98(6):1294","journal-title":"Neuron"},{"issue":"8","key":"5629_CR104","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","volume":"29","author":"MB Victor","year":"2022","unstructured":"Victor MB et al (2022) Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. Cell Stem Cell 29(8):1197-1212 e8","journal-title":"Cell Stem Cell"},{"key":"5629_CR105","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232000","author":"D Toral-Rios","year":"2024","unstructured":"Toral-Rios D et al (2024) Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20232000","journal-title":"J Exp Med"},{"issue":"1","key":"5629_CR106","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12974-020-01869-3","volume":"17","author":"MY Wong","year":"2020","unstructured":"Wong MY et al (2020) 25-hydroxycholesterol amplifies microglial IL-1beta production in an apoE isoform-dependent manner. J Neuroinflammation 17(1):192","journal-title":"J Neuroinflammation"},{"issue":"5","key":"5629_CR107","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1002\/alz.13775","volume":"20","author":"K He","year":"2024","unstructured":"He K et al (2024) APOE epsilon4 is associated with decreased synaptic density in cognitively impaired participants. Alzheimers Dement 20(5):3157\u20133166","journal-title":"Alzheimers Dement"},{"issue":"8006","key":"5629_CR108","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney MS et al (2024) APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature 628(8006):154\u2013161","journal-title":"Nature"},{"issue":"9","key":"5629_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110435","volume":"38","author":"K Lindner","year":"2022","unstructured":"Lindner K et al (2022) Isoform- and cell-state-specific lipidation of ApoE in astrocytes. Cell Rep 38(9):110435","journal-title":"Cell Rep"},{"issue":"13","key":"5629_CR110","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw J et al (2022) Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell 185(13):2213-2233 e25","journal-title":"Cell"},{"issue":"7937","key":"5629_CR111","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW et al (2022) APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611(7937):769\u2013779","journal-title":"Nature"},{"issue":"5","key":"5629_CR112","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1194\/jlr.P083576","volume":"59","author":"V Blanchard","year":"2018","unstructured":"Blanchard V et al (2018) Kinetics of plasma apolipoprotein E isoforms by LC-MS\/MS: a pilot study. J Lipid Res 59(5):892\u2013900","journal-title":"J Lipid Res"},{"key":"5629_CR113","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2015.12.038","volume":"246","author":"KL Rasmussen","year":"2016","unstructured":"Rasmussen KL et al (2016) Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population. Atherosclerosis 246:63\u201370","journal-title":"Atherosclerosis"},{"issue":"33","key":"5629_CR114","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/eurheartj\/ehz402","volume":"40","author":"KL Rasmussen","year":"2019","unstructured":"Rasmussen KL et al (2019) Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort. Eur Heart J 40(33):2813\u20132824","journal-title":"Eur Heart J"},{"issue":"1","key":"5629_CR115","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jalz.2017.05.006","volume":"14","author":"KL Rasmussen","year":"2018","unstructured":"Rasmussen KL et al (2018) Plasma apolipoprotein E levels and risk of dementia: a Mendelian randomization study of 106,562 individuals. Alzheimers Dement 14(1):71\u201380","journal-title":"Alzheimers Dement"},{"issue":"10","key":"5629_CR116","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1038\/s41380-023-02170-4","volume":"28","author":"MM Aslam","year":"2023","unstructured":"Aslam MM et al (2023) Genome-wide analysis identifies novel loci influencing plasma apolipoprotein E concentration and Alzheimer\u2019s disease risk. Mol Psychiatry 28(10):4451\u20134462","journal-title":"Mol Psychiatry"},{"issue":"9","key":"5629_CR117","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/iub.1314","volume":"66","author":"MC Phillips","year":"2014","unstructured":"Phillips MC (2014) Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life 66(9):616\u2013623","journal-title":"IUBMB Life"},{"issue":"35","key":"5629_CR118","doi-asserted-by":"publisher","first-page":"22358","DOI":"10.1016\/S0021-9258(17)31797-0","volume":"269","author":"LM Dong","year":"1994","unstructured":"Dong LM et al (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 269(35):22358\u201322365","journal-title":"J Biol Chem"},{"issue":"53","key":"5629_CR119","doi-asserted-by":"publisher","first-page":"55483","DOI":"10.1074\/jbc.M409324200","volume":"279","author":"J Heeren","year":"2004","unstructured":"Heeren J et al (2004) Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J Biol Chem 279(53):55483\u201355492","journal-title":"J Biol Chem"},{"issue":"1","key":"5629_CR120","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng0996-55","volume":"14","author":"M Miyata","year":"1996","unstructured":"Miyata M, Smith JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14(1):55\u201361","journal-title":"Nat Genet"},{"issue":"4","key":"5629_CR121","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/jcb.10697","volume":"90","author":"L Mabile","year":"2003","unstructured":"Mabile L et al (2003) Secreted apolipoprotein E reduces macrophage-mediated LDL oxidation in an isoform-dependent way. J Cell Biochem 90(4):766\u2013776","journal-title":"J Cell Biochem"},{"issue":"11","key":"5629_CR122","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1074\/jbc.M610712200","volume":"282","author":"M Altenburg","year":"2007","unstructured":"Altenburg M et al (2007) Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner. J Biol Chem 282(11):7817\u20137824","journal-title":"J Biol Chem"},{"issue":"4","key":"5629_CR123","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","volume":"27","author":"A Mor","year":"2007","unstructured":"Mor A et al (2007) Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 27(4):893\u2013900","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5629_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0901-1","volume":"14","author":"G Lo Sasso","year":"2016","unstructured":"Lo Sasso G et al (2016) The Apoe(-\/-) mouse model: a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reduction. J Transl Med 14(1):146","journal-title":"J Transl Med"},{"issue":"1","key":"5629_CR125","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1038\/s41467-018-05322-1","volume":"9","author":"F Bonacina","year":"2018","unstructured":"Bonacina F et al (2018) Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation. Nat Commun 9(1):3083","journal-title":"Nat Commun"},{"key":"5629_CR126","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.physiol.64.081501.155952","volume":"64","author":"PW Shaul","year":"2002","unstructured":"Shaul PW (2002) Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64:749\u2013774","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"5629_CR127","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.112.196667","volume":"60","author":"L Yue","year":"2012","unstructured":"Yue L et al (2012) Apolipoprotein E enhances endothelial-NO production by modulating caveolin 1 interaction with endothelial NO synthase. Hypertension 60(4):1040\u20131046","journal-title":"Hypertension"},{"issue":"37","key":"5629_CR128","doi-asserted-by":"publisher","first-page":"13493","DOI":"10.1073\/pnas.1402106111","volume":"111","author":"V Ulrich","year":"2014","unstructured":"Ulrich V et al (2014) Genetic variants of ApoE and ApoER2 differentially modulate endothelial function. Proc Natl Acad Sci U S A 111(37):13493\u201313498","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"5629_CR129","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/01.RES.0000245479.03190.9f","volume":"99","author":"R DeKroon","year":"2006","unstructured":"DeKroon R et al (2006) APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase\/Akt pathway via the phosphoinositol phosphatase SHIP2. Circ Res 99(8):829\u2013836","journal-title":"Circ Res"},{"issue":"9","key":"5629_CR130","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/clinchem\/45.9.1431","volume":"45","author":"K Yamauchi","year":"1999","unstructured":"Yamauchi K et al (1999) Characterization of apolipoprotein E-containing lipoproteins in cerebrospinal fluid: effect of phenotype on the distribution of apolipoprotein E. Clin Chem 45(9):1431\u20131438","journal-title":"Clin Chem"},{"issue":"5","key":"5629_CR131","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0026-0495(86)90127-7","volume":"35","author":"G Ghiselli","year":"1986","unstructured":"Ghiselli G et al (1986) Plasma catabolism of human apolipoprotein E isoproteins: lack of conversion of the doubly sialylated form to the asialo form in plasma. Metabolism 35(5):399\u2013403","journal-title":"Metabolism"},{"issue":"25","key":"5629_CR132","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.1021\/bi00528a006","volume":"20","author":"VI Zannis","year":"1981","unstructured":"Zannis VI et al (1981) Characterization of the major apolipoproteins secreted by two human hepatoma cell lines. Biochemistry 20(25):7089\u20137096","journal-title":"Biochemistry"},{"issue":"39","key":"5629_CR133","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.1523\/JNEUROSCI.1054-16.2016","volume":"36","author":"C Lane-Donovan","year":"2016","unstructured":"Lane-Donovan C et al (2016) Genetic restoration of plasma ApoE improves cognition and partially restores synaptic defects in ApoE-deficient mice. J Neurosci 36(39):10141\u201310150","journal-title":"J Neurosci"},{"issue":"8","key":"5629_CR134","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","volume":"25","author":"CC Liu","year":"2022","unstructured":"Liu CC et al (2022) Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci 25(8):1020\u20131033","journal-title":"Nat Neurosci"},{"issue":"7","key":"5629_CR135","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.9250","volume":"3","author":"M Koch","year":"2020","unstructured":"Koch M et al (2020) Association of apolipoprotein E in lipoprotein subspecies with risk of dementia. JAMA Netw Open 3(7):e209250","journal-title":"JAMA Netw Open"},{"issue":"2","key":"5629_CR136","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1046\/j.1471-4159.2001.00100.x","volume":"76","author":"D Goti","year":"2001","unstructured":"Goti D et al (2001) Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J Neurochem 76(2):498\u2013508","journal-title":"J Neurochem"},{"issue":"4","key":"5629_CR137","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2004.02373.x","volume":"89","author":"Z Balazs","year":"2004","unstructured":"Balazs Z et al (2004) Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model. J Neurochem 89(4):939\u2013950","journal-title":"J Neurochem"},{"issue":"1","key":"5629_CR138","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2009.03.002","volume":"137","author":"A Zensi","year":"2009","unstructured":"Zensi A et al (2009) Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Control Release 137(1):78\u201386","journal-title":"J Control Release"},{"issue":"1","key":"5629_CR139","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jconrel.2006.12.012","volume":"118","author":"J Kreuter","year":"2007","unstructured":"Kreuter J et al (2007) Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. J Control Release 118(1):54\u20138","journal-title":"J Control Release"},{"key":"5629_CR140","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","volume":"10","author":"J Hu","year":"2015","unstructured":"Hu J et al (2015) Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice. Mol Neurodegener 10:6","journal-title":"Mol Neurodegener"},{"issue":"12","key":"5629_CR141","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1016\/j.ymthe.2024.11.003","volume":"32","author":"C G\u00fcnaydin","year":"2024","unstructured":"G\u00fcnaydin C et al (2024) AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and tau pathology in Alzheimer\u2019s disease mice. Mol Ther 32(12):4303\u20134318","journal-title":"Mol Ther"},{"issue":"1","key":"5629_CR142","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/humc.2017.231","volume":"29","author":"JB Rosenberg","year":"2018","unstructured":"Rosenberg JB et al (2018) AAVrh.10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer\u2019s disease. Hum Gene Ther Clin Dev 29(1):24\u201347","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"19","key":"5629_CR143","doi-asserted-by":"publisher","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","volume":"286","author":"J Brodbeck","year":"2011","unstructured":"Brodbeck J et al (2011) Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J Biol Chem 286(19):17217\u201326","journal-title":"J Biol Chem"},{"issue":"5","key":"5629_CR144","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C et al (2018) Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med 24(5):647\u2013657","journal-title":"Nat Med"},{"issue":"21","key":"5629_CR145","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.1021\/jm3008618","volume":"55","author":"RW Mahley","year":"2012","unstructured":"Mahley RW, Huang Y (2012) Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology. J Med Chem 55(21):8997\u20139008","journal-title":"J Med Chem"},{"issue":"1","key":"5629_CR146","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0306-4522(03)00361-0","volume":"121","author":"D Champagne","year":"2003","unstructured":"Champagne D et al (2003) The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer\u2019s disease. Neuroscience 121(1):99\u2013110","journal-title":"Neuroscience"},{"issue":"5","key":"5629_CR147","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang Q et al (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58(5):681\u2013693","journal-title":"Neuron"},{"issue":"3","key":"5629_CR148","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JAD-160467","volume":"54","author":"A Boehm-Cagan","year":"2016","unstructured":"Boehm-Cagan A et al (2016) ABCA1 agonist reverses the ApoE4-driven cognitive and brain pathologies. J Alzheimers Dis 54(3):1219\u20131233","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"5629_CR149","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.neurobiolaging.2009.07.005","volume":"32","author":"T Vanmierlo","year":"2011","unstructured":"Vanmierlo T et al (2011) Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol Aging 32(7):1262\u20131272","journal-title":"Neurobiol Aging"},{"issue":"2","key":"5629_CR150","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.trci.2016.06.001","volume":"2","author":"K Ghosal","year":"2016","unstructured":"Ghosal K et al (2016) A randomized controlled study to evaluate the effect of bexarotene on amyloid-\u03b2 and apolipoprotein E metabolism in healthy subjects. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions 2(2):110\u2013120","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"5629_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-016-0173-2","volume":"8","author":"JL Cummings","year":"2016","unstructured":"Cummings JL et al (2016) Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer\u2019s disease. Alzheimers Res Ther 8:4","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"5629_CR152","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/mt.2012.33","volume":"20","author":"T Nakayama","year":"2012","unstructured":"Nakayama T et al (2012) Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particles. Mol Ther 20(8):1582\u20131589","journal-title":"Mol Ther"},{"issue":"12","key":"5629_CR153","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1084\/jem.20121274","volume":"209","author":"J Kim","year":"2012","unstructured":"Kim J et al (2012) Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Abeta amyloidosis. J Exp Med 209(12):2149\u20132156","journal-title":"J Exp Med"},{"key":"5629_CR154","doi-asserted-by":"crossref","unstructured":"Huynh TV et al (2017)\u00a0Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of beta-amyloidosis. Neuron 96(5): p. 1013\u20131023 e4","DOI":"10.1016\/j.neuron.2017.11.014"},{"issue":"5","key":"5629_CR155","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.26043","volume":"89","author":"A Litvinchuk","year":"2021","unstructured":"Litvinchuk A et al (2021) Apolipoprotein E4 reduction with antisense oligonucleotides decreases neurodegeneration in a tauopathy model. Ann Neurol 89(5):952\u2013966","journal-title":"Ann Neurol"},{"issue":"4","key":"5629_CR156","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.26864","volume":"95","author":"JM Vance","year":"2024","unstructured":"Vance JM et al (2024) Report of the APOE4 National Institute on Aging\/Alzheimer Disease Sequencing Project Consortium Working Group: reducing APOE4 in carriers is a therapeutic goal for Alzheimer\u2019s disease. Ann Neurol 95(4):625\u2013634","journal-title":"Ann Neurol"},{"issue":"12","key":"5629_CR157","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41587-021-00972-x","volume":"39","author":"T Nagata","year":"2021","unstructured":"Nagata T et al (2021) Cholesterol-functionalized DNA\/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS. Nat Biotechnol 39(12):1529\u20131536","journal-title":"Nat Biotechnol"},{"issue":"212","key":"5629_CR158","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007000","volume":"5","author":"E Hudry","year":"2013","unstructured":"Hudry E et al (2013) Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci Transl Med 5(212):212ra161","journal-title":"Sci Transl Med"},{"issue":"10","key":"5629_CR159","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1038\/s41380-021-01076-3","volume":"26","author":"N Brookhouser","year":"2021","unstructured":"Brookhouser N et al (2021) APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer\u2019s disease. Mol Psychiatry 26(10):5715\u20135732","journal-title":"Mol Psychiatry"},{"issue":"1","key":"5629_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01006-x","volume":"7","author":"S Huang","year":"2022","unstructured":"Huang S et al (2022) Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer\u2019s tau pathology. Signal Transduct Target Ther 7(1):176","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"5629_CR161","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","volume":"287","author":"HK Chen","year":"2012","unstructured":"Chen HK et al (2012) Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem 287(8):5253\u20135266","journal-title":"J Biol Chem"},{"issue":"10","key":"5629_CR162","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1074\/jbc.R800009200","volume":"284","author":"N Zhong","year":"2009","unstructured":"Zhong N, Weisgraber KH (2009) Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure. J Biol Chem 284(10):6027\u20136031","journal-title":"J Biol Chem"},{"key":"5629_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176336","author":"MF Lanfranco","year":"2020","unstructured":"Lanfranco MF, Ng CA, Rebeck GW (2020) ApoE lipidation as a therapeutic target in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21176336","journal-title":"Int J Mol Sci"},{"issue":"6075","key":"5629_CR164","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE et al (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335(6075):1503\u20131506","journal-title":"Science"},{"issue":"25","key":"5629_CR165","doi-asserted-by":"publisher","first-page":"10601","DOI":"10.1073\/pnas.0701096104","volume":"104","author":"N Zelcer","year":"2007","unstructured":"Zelcer N et al (2007) Attenuation of neuroinflammation and Alzheimer\u2019s disease pathology by liver x receptors. Proc Natl Acad Sci U S A 104(25):10601\u201310606","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"5629_CR166","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/1873-3468.13428","volume":"593","author":"E Hubin","year":"2019","unstructured":"Hubin E et al (2019) Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation. FEBS Lett 593(11):1144\u20131153","journal-title":"FEBS Lett"},{"issue":"39","key":"5629_CR167","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1021\/bi051029o","volume":"44","author":"A Chroni","year":"2005","unstructured":"Chroni A et al (2005) SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. Biochemistry 44(39):13132\u201313143","journal-title":"Biochemistry"},{"issue":"21","key":"5629_CR168","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0646-14.2014","volume":"34","author":"F Liao","year":"2014","unstructured":"Liao F et al (2014) Anti-ApoE antibody given after plaque onset decreases Abeta accumulation and improves brain function in a mouse model of Abeta amyloidosis. J Neurosci 34(21):7281\u20137292","journal-title":"J Neurosci"},{"issue":"5","key":"5629_CR169","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao F et al (2018) Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest 128(5):2144\u20132155","journal-title":"J Clin Invest"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05629-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T23:03:11Z","timestamp":1766530991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05629-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":169,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5629"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05629-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"325"}}